Zwart, Eline S.
van Ee, Thomas
Affandi, Alsya J.
Boyd, Lenka N. C.
Rodriguez, Ernesto
den Haan, Joke M. M.
Farina, Arantza
van Grieken, Nicole C. T.
Meijer, Laura L.
van Kooyk, Yvette
Mebius, Reina E.
Kazemier, Geert
Funding for this research was provided by:
Cancer Center Amsterdam (2017-4-09, 2017-4-09, 2017-4-09)
Bennink Foundation (2005619, 2005619, 2005619, 2005619)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (09150162010163)
ZonMw
European Research Council (ERC-339977-Glycotreat, ERC-339977-Glycotreat)
KWF Kankerbestrijding (VU2019-12802, VU2019-12802)
Article History
Received: 10 August 2023
Accepted: 24 October 2023
First Online: 8 November 2023
Declarations
:
: The authors declare that they have no conflict of interest.
: The study design and protocol were approved by the local Medical Ethics Board of the Amsterdam UMC, VU University, Amsterdam, (NL) (2016.59), in accordance with the ethical guidelines of the Declaration of Helsinki.
: Written informed consent was obtained from all participants before study participation.
: Not applicable.